Highland Capital Management (Texas)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Highland Capital Management (Texas)’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-237,822	Closed	-$3.37M	–	269
2014 Q4	$3.37M	Sell	237,822 -87,644	-27%	-$1.36M	0.11%	119
2014 Q3	$4.47M	Buy	+325,466	New	+$4.98M	0.17%	113
2014 Q2	–	Sell	-80,000	Closed	-$1.36M	–	322
2014 Q1	$1.36M	Buy	80,000 +53,895	+206%	+$813K	0.05%	144
2013 Q4	$338K	Buy	+26,105	New	+$312K	0.02%	159

Other funds holding KERX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Highland Capital Management (Texas)'s KERX Position: Q1 2015 in Review

Highland Capital Management (Texas) sold out of Keryx Biopharmaceuticals Inc (KERX) in Q1 2015, closing a stake of 237,822 shares — an estimated $3.37M sold.

Highland Capital Management (Texas) first reported a position in KERX in Q4 2013 and held it in 4 quarters. The position peaked at $4.47M in Q3 2014. 157 funds tracked by Wall St. Rank hold KERX as of Q1 2015.

Highland Capital Management (Texas) reported no remaining Keryx Biopharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
Highland Capital Management (Texas) sold 237,822 Keryx Biopharmaceuticals Inc shares in Q1 2015, an estimated $3.37M.
Highland Capital Management (Texas) first reported a position in Keryx Biopharmaceuticals Inc in Q4 2013 and held it in 4 quarters.
Highland Capital Management (Texas)'s Keryx Biopharmaceuticals Inc position peaked at $4.47M in Q3 2014.
157 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q1 2015.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2015, filed 15 May 2015.